Work

Thirty years with LIFE—a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy

Year: 2022

Type: editorial

Abstract: Losartan Intervention for Endpoint Reduction in hypertension (LIFE) is the only large clinical trial of antihypertensive treatment ever performed in hypertensive patients with left ventricular hype...

Source: Blood Pressure

DOI: 10.1080/08037051.2022.2083578

Authors: Sverre E. Kjeldsen, Brent M. Egan, Krzysztof Narkiewicz, Reinhold Kreutz, Michel Burnier, Suzanne Oparil

Institutions: University of Oslo, University of South Carolina, American Medical Association, Gdańsk Medical University, Charité - Universitätsmedizin Berlin, University of Lausanne, University of Alabama at Birmingham, UAB Medicine

Language: English

Topic: Blood Pressure and Hypertension Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,650

OpenAlex ID: W4282919542

Cites: 11

Cited by:

Related to: 10